$JNJ Company News Apple as the Comeback Kid 1:13 p.m.

New Post Public Reply Private Reply Replies (0) Message Board

Mar 19, 2014 at 10:27 AM

$JNJ Company News

Apple as the Comeback Kid 1:13 p.m. March 13, 2014 - Mark Hulbert
The well is running dry for big oil 6:00 a.m. March 3, 2014 - Jeff Reeves
West Coast Asset Management’s top holdings 12:29 p.m. Feb. 28, 2014 - Insider Monkey
Best stocks for legalized marijuana 1:37 p.m. Feb. 27, 2014 - blogs.marketwatch.com
Billionaire Stan Druckenmiller's recent moves 11:50 a.m. Feb. 24, 2014 - Insider Monkey
You'd have to be a dope to buy marijuana stocks 1:36 p.m. Feb. 13, 2014 - blogs.marketwatch.com
FDA approval of leukemia treatment boosts shares of Pharmacyclics 1:57 p.m. Feb. 12, 2014 - blogs.marketwatch.com
Goldman: The 4 biggest themes of earnings season 8:06 a.m. Feb. 12, 2014 - blogs.marketwatch.com
10 stocks to beat a declining market 3:01 p.m. Feb. 7, 2014 - Mark Hulbert
Feds, pharma rivals team up on Alzheimer's 2:32 p.m. Feb. 6, 2014 - blogs.marketwatch.com
CVS move won’t slow e-cigarette sales 4:42 p.m. Feb. 5, 2014 - Jonnelle Marte
Newscast: Stocks mixed to start short week 6:32 p.m. Jan. 21, 2014 - MarketWatch
U.S. stocks close higher; earnings misses drag on Dow 4:51 p.m. Jan. 21, 2014 - Anora Mahmudova
Newscast: Stocks open week mixed 4:32 p.m. Jan. 21, 2014 - MarketWatch
Nasdaq nabs 13-year high, but Dow slips: stock market live blog recap 4:05 p.m. Jan. 21, 2014 - blogs.marketwatch.com
Ken Fisher's new top stock picks 2:48 p.m. Jan. 21, 2014 - Insider Monkey
Johnson & Johnson shares take a hit on full-year outlook 11:27 a.m. Jan. 21, 2014 - blogs.marketwatch.com
Newscast: Demand soars for humanely-raised pork 10:00 a.m. Jan. 21, 2014 - MarketWatch
Johnson & Johnson’s profit jumps 37% 9:49 a.m. Jan. 21, 2014 - Tess Stynes
Stock futures rise after China’s cash injections 9:32 a.m. Jan. 21, 2014 - Barbara Kollmeyer

Shareholder Yield: Are The Companies You're Invested In Investing In You? 15 min ago - Seeking Alpha
Will This Target Price Increase Help Johnson & Johnson (JNJ) Today? 9:09 a.m. Today - TheStreet.com
How Does An Intelligent Investor Navigate Mortgage REIT Risk? 8:48 a.m. Today - Seeking Alpha
Veteran Investor's Top Biotech and Drug Stocks 7:57 a.m. Today - Barrons.com
Dividend Growth Investing: An Introduction To Creating Wealth 7:33 a.m. Today - Seeking Alpha
Cramer's Mad Money - Profits, Not Putin (3/18/14) 6:18 a.m. Today - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: Profits Still Matter 8:07 p.m. March 18, 2014 - TheStreet.com
Abbott Capturing Incremental Market Share 6:27 p.m. March 18, 2014 - GuruFocus.com
Abbvie's Humira Continues to be a Powerful Catalyst for Growth 6:07 p.m. March 18, 2014 - GuruFocus.com
March Dividend Madness - How Are You Positioned? 3:47 p.m. March 18, 2014 - Seeking Alpha
Alberta Diabetes Research Receives a Big Boost 2:13 p.m. March 18, 2014 - CNW Group
Hoya's Prospects Brightened By Life Care 11:39 a.m. March 18, 2014 - Seeking Alpha
This Blue Chip Keeps Bouncing Back 2:38 p.m. March 17, 2014 - Seeking Alpha
Interesting May Stock Options For JNJ 12:04 p.m. March 17, 2014 - TheStreet.com
The 5 Best Index Funds for Optimists 5:35 a.m. March 17, 2014 - InvestorPlace.com
Rich And Retired? It Is ALL About Capital Preservation, Folks! 8:24 a.m. March 16, 2014 - Seeking Alpha
Dividend Champions: 14 Increases Expected By The End Of May 5:00 p.m. March 15, 2014 - Seeking Alpha
J&J Lawsuit Sheds Light on Link Between Doctors and Device Makers 4:43 p.m. March 14, 2014 - Wall St. Cheat Sheet
Johnson & Johnson Rolls Out New Products, Dividends 4:16 p.m. March 14, 2014 - Investors Business Daily
Blue Light Specials In The Market: Healthcare 2:12 p.m. March 14, 2014 - Seeking Alpha

Health Care Stocks Review -- Research on Bristol-Myers Squibb, Johnson & Johnson, Merck & Co. and Eli Lilly 8:00 a.m. Today - PR Newswire - PRF
Critical Alerts For Comcast, Johnson and Johnson, AIG, ARM Holdings, and ConocoPhillips Released By InvestorsObserver 9:31 a.m. March 17, 2014 - PR Newswire - PRF
Philadelphia Jury Awards $3 Million in Topamax Birth Defect Trial 12:44 p.m. March 14, 2014 - PR Newswire - PRF
Spend Management Industry Flocks to NextLevel 2014 9:02 a.m. March 12, 2014 - BusinessWire - BZX
Collaborations, Treatment Approvals, New Solutions, Clinical Trial Results, and New Drug Applications - Analyst Notes on Biogen Idec, Johnson & Johnson, Express Scripts, Merck, and Forest Laboratories 8:00 a.m. March 12, 2014 - PR Newswire - PRF
Johnson & Johnson to Host Analyst Conference Call on First-Quarter Results 4:15 p.m. March 11, 2014 - PR Newswire - PRF
Risperdal Lawsuit in Montana Ends in $5.9 Million Settlement, Bernstein Liebhard LLP Reports 11:50 a.m. March 10, 2014 - PR Newswire - PRF
e-Nicotine Technology to Bring Electronic Nicotine Delivery Products to Market to Address Key Unmet Needs for Smokers and the Public Health Community 10:09 a.m. March 10, 2014 - BusinessWire - BZX
Alector Teams Up with Johnson & Johnson Innovation to Explore Novel Alzheimer's Target 8:00 a.m. March 10, 2014 - PR Newswire - PRF
Simmons Law Firm Reports: Philadelphia Jury Rules Johnson & Johnson Subsidiary Must Pay $3 Million For Child's Birth Injuries 7:45 a.m. March 10, 2014 - PR Newswire - PRF
Pharma-Biotech Industry Helps Drive $14.4 Billion Industrial Project Activity in Massachusetts, an Industrial Info News Alert 6:30 a.m. March 10, 2014 - Marketwire
Johnson & Johnson Launches "Champions of Care" Program in the U.S as Part of 2014 FIFA World Cup™ Sponsorship 1:52 p.m. March 6, 2014 - PR Newswire - PRF
Top Advertising Firm Deutsch Leverages Dot Hill AssuredSAN Arrays to Replicate Data From New York to Los Angeles 9:24 a.m. March 6, 2014 - GlobeNewswire
Mindflash Used to Deliver 1 Million Online Training Courses in 2013 7:30 a.m. March 6, 2014 - Marketwire
BioClinica European User Conference Reflects Expansion Trend In Europe 8:48 a.m. March 5, 2014 - PR Newswire - PRF
Synta Announces Executive Management Changes, Appoints Dr. Paul A. Friedman Director 4:01 p.m. March 3, 2014 - BusinessWire - BZX
Risperdal Lawsuit News: Arkansas Supreme Court Hears Johnson & Johnson Appeal of $1.2 Billion Risperdal Verdict, Bernstein Liebhard LLP Reports. 11:31 a.m. Feb. 28, 2014 - PR Newswire - PRF
Voce Capital Responds to ConMed Board Changes 5:16 p.m. Feb. 27, 2014 - BusinessWire - BZX
Translational Regenerative Medicine: Market Prospects 2014-2024 11:35 a.m. Feb. 27, 2014 - PR Newswire - PRF
Dr. Martin Madaus to be Named Chairman and CEO of Ortho-Clinical Diagnostics (OCD) 11:00 a.m. Feb. 27, 2014 - BusinessWire - BZX

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Surfing Dogs Ride Waves, Support Orphan Pets

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

GORGIE Unleashes Berry Burst: Target's New Drink Star

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

PwC US and India Unite for Global Consultancy Powerhouse

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Ris-Rez May Set New Standard in Relapsed SCLC

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Tam-Peli Steps Up in SCLC Battle: Trial Insights

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

UWM Faces Class Action Deadline: Key Insights for Investors

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Trial Disappointment: No Significant Gains in NSCLC

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

MRI Surveillance Gains Ground in Lung Cancer Care

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....